Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and postoperative awakening under sevoflurane in elderly non-cardiac surgery
ChiCTR2500109724Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in postoperative delirium (POD), postoperative pain and Irregular sleep-wake rhythm disorder (ISWRD) (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Awakening time, Incidence of postoperative delirium and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative delirium (POD)postoperative painIrregular sleep-wake rhythm disorder (ISWRD)
Beyond the preview
Go deeper on ChiCTR2500109724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109724.